Virtual Reality Cognitive Training for Mild Cognitive Impairment - Trial NCT06380894
Access comprehensive clinical trial information for NCT06380894 through Pure Global AI's free database. This phase not specified trial is sponsored by Changi General Hospital and is currently Completed. The study focuses on Mild Cognitive Impairment. Target enrollment is 20 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Changi General Hospital
Timeline & Enrollment
N/A
Jan 27, 2021
Jan 31, 2023
Primary Outcome
Change from Baseline in Memory Performance on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) subtests at Week 11,Change from Baseline in Attention Performance on the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) subtest at Week 11,Change from Baseline in Attention Performance on the Colour Trails Test 1 at Week 11,Change from Baseline in Executive Function Performance on the Frontal Assessment Battery (FAB) at Week 11,Change from Baseline in Executive Function Performance on the Colour Trails Test 2 at Week 11
Summary
This study aims to assess the feasibility and efficacy of a 10-weekly multi-domain VRCT
 program on the cognitive function (i.e. attention, memory, and executive functioning) of
 older adults with MCI.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06380894
Device Trial